Colorectal Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Colorectal Cancer, including details on symptoms, genetics, screening, treatment, information.

Volume 3 (2006), Issue 5 (May)

1. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases.
   J Clin Oncol, 24(13): 2065-72. [Abstract] [Full-text]
2. Oral uracil and tegafur plus leucovorin compared with intravenous fluorouracil and leucovorin in stage II and III carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project Protocol C-06.
   J Clin Oncol, 24(13): 2059-64. [Abstract] [Full-text]
3. Vulvar, vaginal, and perianal intraepithelial neoplasia in women with or at risk for human immunodeficiency virus.
   Obstet Gynecol, 107(5): 1023-8. [Abstract] [Full-text]
4. Number of lymph node metastases is better predictor of prognosis than level of lymph node metastasis in patients with node-positive colon cancer.
   J Am Coll Surg, 202(5): 732-6. [Abstract] [Full-text]
5. p16(INK4a) promoter methylation and 9p21 allelic loss in colorectal carcinomas: relation with immunohistochemical p16(INK4a) expression and with tumor budding.
   Hum Pathol, 37(5): 578-85. [Abstract] [Full-text]
6. Initial experience with a general population colorectal cancer screening clinic.
   Am J Surg, 191(5): 669-72. [Abstract] [Full-text]
7. Ex vivo sentinel lymph node mapping in colon cancer: improving the accuracy of pathologic staging?
   Am J Surg, 191(5): 665-8. [Abstract] [Full-text]
8. A prospective analysis of microsatellite instability as a molecular marker in colorectal cancer.
   Am J Surg, 191(5): 646-51. [Abstract] [Full-text]
9. The BH3-only protein, PUMA, is involved in oxaliplatin-induced apoptosis in colon cancer cells.
   Biochem Pharmacol, 71(11): 1540-50. [Abstract] [Full-text]
10. Elevated Golgi pH in breast and colorectal cancer cells correlates with the expression of oncofetal carbohydrate T-antigen.
    J Cell Physiol, 208(1): 167-74. [Abstract] [Full-text]
11. Novel method for high throughput DNA methylation marker evaluation using PNA-probe library hybridization and MALDI-TOF detection.
    Nucleic Acids Res, 34(8): e59. [Abstract] [Full-text]
12. Completion of therapy by Medicare patients with stage III colon cancer.
    J Natl Cancer Inst, 98(9): 610-9. [Abstract] [Full-text]
13. A phase II study of FOLFIRI-3 (double infusion of irinotecan combined with LV5FU) after FOLFOX in advanced colorectal cancer patients.
    Br J Cancer, 94(9): 1287-92. [Abstract] [Full-text]
14. Thrombomodulin expression in colorectal carcinoma is protective and correlates with survival.
    Br J Cancer, 94(9): 1320-5. [Abstract] [Full-text]
15. Phase II trial of combined irinotecan and oxaliplatin given every 3 weeks to patients with metastatic colorectal cancer.
    Cancer, 106(10): 2241-6. [Abstract] [Full-text]
16. ACTIBIND, an actin-binding fungal T2-RNase with antiangiogenic and anticarcinogenic characteristics.
    Cancer, 106(10): 2295-308. [Abstract] [Full-text]
17. Crypt dynamics and colorectal cancer: advances in mathematical modelling.
    Cell Prolif, 39(3): 157-81. [Abstract] [Full-text]
18. Location of early colorectal cancers at fold-top may reduce the risk of lymph node metastasis.
    Dis Colon Rectum, 49(5): 579-87. [Abstract] [Full-text]
19. Impact of functional results on quality of life after rectal cancer surgery.
    Dis Colon Rectum, 49(5): 568-78. [Abstract] [Full-text]
20. Early prediction of anastomotic leak in colorectal cancer surgery by intramucosal pH.
    Dis Colon Rectum, 49(5): 595-601. [Abstract] [Full-text]
21. Immunohistochemical expression of p16, p53, and p63 in colorectal adenomas and adenocarcinomas.
    Dis Colon Rectum, 49(5): 588-94. [Abstract] [Full-text]
22. Impact of the cyclin D1 A870G polymorphism on susceptibility to sporadic colorectal cancer in Taiwan.
    Dis Colon Rectum, 49(5): 602-8. [Abstract] [Full-text]
23. Clinical, pathologic, and immunohistochemical characteristics of gastrointestinal stromal tumors of the colon and rectum: implications for surgical management and adjuvant therapies.
    Dis Colon Rectum, 49(5): 609-15. [Abstract] [Full-text]
24. Influence of intraoperative and postoperative radiotherapy on functional outcome in patients undergoing standard and deep anterior resection for rectal cancer.
    Dis Colon Rectum, 49(5): 557-67. [Abstract] [Full-text]
25. Colonoscopy in the elderly: low risk, low yield in asymptomatic patients.
    Dis Colon Rectum, 49(5): 646-51. [Abstract] [Full-text]
26. Colorectal cancer model of health disparities: understanding mortality differences in minority populations.
    J Clin Oncol, 24(14): 2179-87. [Abstract] [Full-text]
27. Allele-specific loss of heterozygosity in multiple colorectal adenomas: toward an integrated molecular cytogenetic map II.
    Cancer Genet Cytogenet, 167(1): 1-14. [Abstract] [Full-text]
28. Differential expression proteomics of human colon cancer.
    Am J Physiol Gastrointest Liver Physiol, 290(6): G1329-38. [Abstract] [Full-text]
29. Lymph nodes in colorectal carcinoma. The Poisson probability paradigm.
    Am J Clin Pathol, 125(6): 866-72. [Abstract] [Full-text]
30. A cost-effective algorithm for hereditary nonpolyposis colorectal cancer detection.
    Am J Clin Pathol, 125(6): 823-31. [Abstract] [Full-text]
31. MRI identified prognostic features of tumors in distal sigmoid, rectosigmoid, and upper rectum: treatment with radiotherapy and chemotherapy.
    Int J Radiat Oncol Biol Phys, 65(2): 445-51. [Abstract] [Full-text]
32. Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience.
    Int J Radiat Oncol Biol Phys, 65(2): 412-25. [Abstract] [Full-text]
33. Expression of PRL proteins at invasive margin of rectal cancers in relation to preoperative radiotherapy.
    Int J Radiat Oncol Biol Phys, 65(2): 452-8. [Abstract] [Full-text]
34. Clinical performance of original and revised Bethesda guidelines for the identification of MSH2/MLH1 gene carriers in patients with newly diagnosed colorectal cancer: proposal of a new and simpler set of recommendations.
    Am J Gastroenterol, 101(5): 1104-11. [Abstract] [Full-text]
35. Mismatch repair status in the prediction of benefit from adjuvant fluorouracil chemotherapy in colorectal cancer.
    Gut, 55(6): 848-55. [Abstract] [Full-text]
36. 5-fluorouracil-related gene expression levels in primary colorectal cancer and corresponding liver metastasis.
    Int J Cancer, 119(3): 522-6. [Abstract] [Full-text]
37. Cigarette smoking and colorectal cancer risk in Germany: a population-based case-control study.
    Int J Cancer, 119(3): 630-5. [Abstract] [Full-text]
38. Up-regulation of cyclooxygenase-2 by interleukin-1beta in colon carcinoma cells.
    Cell Signal, 18(8): 1262-9. [Abstract] [Full-text]
39. Solitary colorectal liver metastasis: resection determines outcome.
    Arch Surg, 141(5): 460-6; discussion 466-7. [Abstract] [Full-text]
40. Total pelvic exenteration: the Albert Einstein College of Medicine/Montefiore Medical Center Experience (1987 to 2003).
    Gynecol Oncol, 101(2): 261-8. [Abstract] [Full-text]
41. The contribution of the hereditary nonpolyposis colorectal cancer syndrome to the development of ovarian cancer.
    Gynecol Oncol, 101(2): 238-43. [Abstract] [Full-text]
42. Can MRI rule out bladder and rectal invasion in cervical cancer to help select patients for limited EUA?
    Gynecol Oncol, 101(2): 244-9. [Abstract] [Full-text]
43. Major colorectal surgery in a patient with cold agglutinin disease.
    Anaesthesia, 61(6): 593-6. [Abstract] [Full-text]
44. ETV4 and Myeov knockdown impairs colon cancer cell line proliferation and invasion.
    Biochem Biophys Res Commun, 345(1): 216-21. [Abstract] [Full-text]
45. Immunohistochemical test for MLH1 and MSH2 expression predicts clinical outcome in stage II and III colorectal cancer patients.
    J Clin Oncol, 24(15): 2359-67. [Abstract] [Full-text]
46. Duration of adjuvant chemotherapy for colon cancer and survival among the elderly.
    J Clin Oncol, 24(15): 2368-75. [Abstract] [Full-text]
47. Risk factors for obstruction, perforation, or emergency admission at presentation in patients with colorectal cancer: a population-based study.
    Am J Gastroenterol, 101(5): 1098-103. [Abstract] [Full-text]
48. Polyp volume versus linear size measurements at CT colonography: implications for noninvasive surveillance of unresected colorectal lesions.
    AJR Am J Roentgenol, 186(6): 1605-10. [Abstract] [Full-text]
49. Portal vein embolisation prior to hepatic resection for colorectal liver metastases and the effects of periprocedure chemotherapy.
    Br J Radiol, 79(942): 473-8. [Abstract] [Full-text]
50. Outcomes of resection of stage IV rectal cancer with mesorectal excision.
    J Surg Oncol, 93(7): 523-8. [Abstract] [Full-text]
51. Preoperative chemoradiation in rectal cancer: Retrospective comparison between capecitabine and continuous infusion of 5-fluorouracil.
    J Surg Oncol, 93(7): 529-33. [Abstract] [Full-text]
52. Risk of developing colorectal cancer following a negative colonoscopy examination: evidence for a 10-year interval between colonoscopies.
    JAMA, 295(20): 2366-73. [Abstract] [Full-text]
53. Screening colonoscopy in very elderly patients: prevalence of neoplasia and estimated impact on life expectancy.
    JAMA, 295(20): 2357-65. [Abstract] [Full-text]
54. Management of involved or close resection margins in 120 patients with colorectal liver metastases: edge cryotherapy can achieve long-term survival.
    Am J Surg, 191(6): 735-42. [Abstract] [Full-text]
55. Randomized clinical trial to evaluate the effects of perioperative supplemental oxygen administration on the colorectal anastomosis.
    Br J Surg, 93(6): 698-706. [Abstract] [Full-text]
56. Insufficient ability of omental milky spots to prevent peritoneal tumor outgrowth supports omentectomy in minimal residual disease.
    Cancer Immunol Immunother, 55(9): 1043-51. [Abstract] [Full-text]
57. Active treatment of murine tumors with a highly attenuated vaccinia virus expressing the tumor associated antigen 5T4 (TroVax) is CD4+ T cell dependent and antibody mediated.
    Cancer Immunol Immunother, 55(9): 1081-90. [Abstract] [Full-text]
58. NK cell activation by dendritic cell vaccine: a mechanism of action for clinical activity.
    Cancer Immunol Immunother, 55(9): 1122-31. [Abstract] [Full-text]
59. Increased integrity of free circulating DNA in sera of patients with colorectal or periampullary cancer: direct quantitative PCR for ALU repeats.
    Clin Chem, 52(6): 1062-9. [Abstract] [Full-text]
60. Overexpression of hRFI inhibits 5-fluorouracil-induced apoptosis in colorectal cancer cells via activation of NF-kappaB and upregulation of BCL-2 and BCL-XL.
    Oncogene, 25(22): 3160-9. [Abstract] [Full-text]
61. Phase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901.
    J Clin Oncol, 24(16): 2557-62. [Abstract] [Full-text]

© 2004-2008 Colorectal Cancer Research Today. All Rights Reserved.